Neo Ivy Capital Management Emergent Bio Solutions Inc. Transaction History

Neo Ivy Capital Management

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$27.42 - $43.63 $14,093 - $22,425	-514 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $18,750 - $26,841	514 New	514 $22,000
Q4 2021 Feb 15, 2022	SELL	$33.11 - $55.01 $3,873 - $6,436	-117 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$50.07 - $66.05 $5,858 - $7,727	117 New	117 $9,000
Q1 2021 Oct 07, 2021	SELL	$86.23 - $125.19 $34,750 - $50,451	-403 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $27,076 - $38,122	342 Added 560.66%	403 $36,000
Q3 2020 Nov 17, 2020	BUY	$81.91 - $134.94 $4,996 - $8,231	61 New	61 $6,000
Q2 2020 Aug 17, 2020	SELL	$54.33 - $89.52 $6,356 - $10,473	-117 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$54.33 - $89.52 $24,013 - $39,567	-442 Reduced 79.07%	117 $9,000
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $27,581 - $38,436	559 New	559 $32,000
Q2 2019 Aug 15, 2019	SELL	$39.92 - $53.86 $426,465 - $575,386	-10,683 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $195,235 - $267,815	4,048 Added 61.01%	10,683 $539,000
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $369,105 - $485,947	6,635 New	6,635 $393,000

158

32.6M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $385M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.